background: The study of human endometrial-embryonic interactions is complicated by the disruptive impact of endometrial sample collection on the process of implantation itself. Endometrial secretion analysis is a novel technique, non-disruptive to implantation. The primary aim of this prospective cohort study was to explore whether a cytokine profile predictive of implantation and clinical pregnancy can be identified in endometrial secretions aspirated immediately prior to embryo transfer following IVF.
Introduction
Embryo implantation failure remains the major rate-limiting step in IVF success. Successful implantation and pregnancy require a vital embryo and an effective molecular dialogue with a 'receptive' endometrium (Wang and Dey, 2006) . However, what precisely constitutes a receptive human endometrium remains poorly defined. The human endometrium appears to be receptive to implantation for a limited time period during the mid-luteal phase of the normo-ovulatory cycle (Ma et al., 2003) . The duration of this putative 'window of implantation' is primarily determined by sex steroids (Dey et al., 2004) , which regulate the expression of locally acting growth factors, transcription factors, cytokines and chemokines (Dey et al., 2004; Wang and Dey, 2006) . In recent years, our understanding of the molecular pathways regulating implantation has been increased by the identification of genes whose expression is cyclically regulated in the endometrium (Talbi et al., 2006) . Studies in mice have identified a number of key regulators which appear to be crucial for normal implantation (Stewart et al., 1992) . However, up to now, no single specific factor has been identified as being crucial for implantation in humans (Strowitzki et al., 2006) . The continuing high rate of implantation failure observed in assisted reproduction technologies has driven the search for clinical markers of endometrial receptivity. Many candidate markers have been proposed, including integrins, glycodelin and leukemia inhibitory factor (LIF) (Lessey et al., 1995; Chryssikopoulos et al., 1996; Ledee-Bataille et al., 2002) . However, none have as yet been shown to be valuable clinically.
Although global gene array and histochemical studies are increasing our knowledge of the molecular regulation of the receptive endometrium, unraveling the molecular pathways of human implantation is hampered by the requirement of appropriately timed endometrial biopsies, which themselves disrupt the necessary end-point of implantation (van der Gaast et al., 2003) . Recently, our group has developed a novel means of assessing the intrauterine milieu, by endometrial secretion analysis. We have shown this approach to be non-disruptive to implantation and representative of the in vivo milieu encountered by the embryo (van der Gaast et al., 2003; Boomsma et al., 2009) . Uterine glands produce a glycoprotein-rich secretion, which is believed to support the embryo during the preimplantation period (Burton et al., 2002) . In addition to providing nutrition for the conceptus, it contains a complex array of growth factors and cytokines. Modern multiplex immunoassays enable multiple markers to be quantified simultaneously in a small volume (de Jager et al., 2003) . Recently we have reported the application of a multiplex immunoassay to determine multiple cytokine, chemokine, growth and signaling factors in a single endometrial secretion sample (Boomsma et al., 2009) . A brief description of the roles in implantation of these mediators is provided in Supplementary Material, Table S1 .
Increasing evidence points to pre-clinical pregnancy loss rather than failure of implantation as a principal cause for the relatively low fecundity observed in humans. In natural cycles, up to 60% of conceptions are estimated to be lost owing to pre-clinical pregnancy loss (Macklon et al., 2002) . It is uncertain to what extent failure of IVF treatment can be attributed to early rejection of the implanted embryo. The primary aim of this study was to explore whether a profile of markers, identified in endometrial secretions aspirated immediately prior to embryo transfer following IVF/ICSI treatment, is predictive of pregnancy. However, since not all embryo implantations proceed into a clinical pregnancy, the early implantation of embryos was also assessed. The secondary aim was to discern the contribution of early rejection of the implanting embryo to the failure to achieve pregnancy after IVF.
Materials and Methods
Ethical approval was obtained from the local institutional committee and informed consent was obtained from all participants. Between December 2005 and October 2006, we recruited 248 women attending the University Medical Center Utrecht (The Netherlands) for IVF/ ICSI treatment to participate in this prospective cohort study. None had undergone more than one prior unsuccessful embryo transfer. No additional exclusion criteria were applied.
As described previously in detail (Boomsma et al., 2009) , ovarian stimulation to obtain multiple oocytes was carried out by daily injections of recombinant FSH (100-300 IU/day) from cycle Day 2 or 3 of a spontaneous cycle onwards. To prevent premature luteinization, co-treatment with a GnRH antagonist (0.25 mg/day) was provided from stimulation Day 5 in IVF cycles. No oral contraceptives for cycle regulation were provided in GnRH antagonist cycles. The majority of ICSI cycles were performed using a long GnRH agonist suppression protocol from cycle Day 21 of the previous cycle for logistic considerations. Final oocyte maturation was triggered with a single subcutaneous injection of human Chorionic Gonadotropin (hCG) (Pregnyl: 10 000 IU). A maximum of two embryos were transferred 4 days after oocyte retrieval. Women under the age of 36 years were restricted to single-embryo transfer if a high-quality embryo was available, which was defined as a compacted morula-stage embryo 4 days after oocyte retrieval with 0-10% fragmentation. Following embryo transfer, the luteal phase was supported with three injections of hCG in 5 days (Pregnyl: 5000 IU), or by daily vaginal progesterone treatment (Progestan: 600 mg/day).
Endometrial secretion aspiration procedure
We aspirated endometrial secretions immediately prior to embryo transfer, as described previously (Boomsma et al., 2009) . Briefly, an embryo transfer catheter (Wallace: sIMS Portex Ltd, Hythe, Kent, UK) was introduced transcervically. Suction was gradually applied with a 2 ml syringe. Contamination by cervical mucus was prevented as described previously (Boomsma et al., 2009) . The aspirate was snap-frozen in liquid nitrogen and stored at 2808C.
Sample analysis

Determination of the cytokine profile
The procedure employed to analyze the endometrial secretions has been described in detail (Boomsma et al., 2009) previously. We analyzed endometrial secretion samples using a multiplex immunoassay detecting 17 soluble mediators. Mediators were eligible for inclusion in the panel when appropriate antibodies were available and no crossinterference occurred. It has been shown previously that the intra-assay variance of the multiplex immunoassay was ,10%, whereas inter-assay variance ranged from 6-16% (de Jager et al., 2003) . Since concentrations of macrophage migration inhibitory factor (MIF) in most samples exceeded the maximal detectable concentration of the multiplex assay, MIF was determined in diluted samples using a commercially available enzyme-linked immunosorbent assay (R&D systems, Abingdon, UK). The volumes of the aspirates could not be measured accurately owing to their viscous quality and small volume (around 3 ml). Therefore, the total protein concentration was measured by NanoOrange Protein Quantitation Kit (Molecular Probes Europe B.V., Leiden, The Netherlands) for normalization purposes. To recover samples from the frozen catheter tip, 70 ml phosphate-buffered saline was added, and 50 ml of each sample was used for the multiplex immunoassay. The lower detection limits of the multiplex immunoassay were as follows: interleukin (IL)-b (0.6 pg/ml), IL-5 (2.4 pg/ml), IL-6 (1.2 pg/ml), IL-10 (1.2 pg/ml), IL-12 (4.9 pg/ml), IL-15 (1.2 pg/ml), IL-17 (2.4 pg/ml), IL-18 (1.2 pg/ml), tumor necrosis factor (TNF)-a (2.4 pg/ml), interferon (IFN)-g (2.4 pg/ml), heparin-binding epidermal growth factor (1.2 pg/ml), vascular endothelial growth factor (VEGF) (1.2 pg/ml), IFN-g-inducible 10 kDa protein (IP-10) (1.2 pg/ml), monocyte chemo-attractant protein-1 (MCP-1) (1.2 pg/ml), Dickkopf homolog 1 (DKK-1) (78 pg/ml), eotaxin (2.4 pg/ml). The lower detection limit for macrophage MIF was 32 pg/ml.
Detection of implantation
In order to detect an embryo implantation, all participants were asked to freeze a urine sample from Day 9 until Day 18 after oocyte retrieval. After thawing, we dephosphorylated urine samples with calcium chloride and incubated 0.5 ml of this sample overnight in a test unit. After fluid aspiration from the units, the test units were analyzed in the Immulite 1000 w immunoanalyzer (Siemens). The functional sensitivity of the assay was 0.06 mU/ml with 20% coefficient of variation. The day-to-day variation at three hCG concentration levels was 0.14 mU/ml +6.0%, 1.2 mU/ml +3.9% and 4.9 mU/ml +3.6%. The assay was calibrated against the National Institute for Biological Standards and Controls hCG Standard 99/688. In order to correct for variations in urine concentration, hCG levels were corrected for creatinine concentrations.
Since subjects received a standard dose of exogenous hCG to trigger final oocyte maturation 36 h prior to oocyte retrieval, it was necessary to differentiate between endogenous hCG produced by an implanting conceptus and residual hCG derived from exogenous administration. Therefore we generated hCG wash-out curves by analysis of urine samples collected 9-15 days after oocyte retrieval from 10 oocyte donors who had received a similar dose of hCG (10 000 IU) ( Fig. 1 ). We calculated a cut-off value from the wash-out curves by adding two SDs to the mean concentration hCG on each day. Implantation was considered to have occurred when urinary hCG levels were more than 2 SDs above the mean wash-out curve value on 2 consecutive days. Women who received hCG rather than progesterone for luteal support were excluded from this analysis. A urinary pregnancy test was performed 18 days after oocyte retrieval. When a rise in urinary hCG levels indicative of implantation was followed by a negative pregnancy test, a preclinical pregnancy loss was considered to have occurred. A clinically recognized pregnancy was defined by a positive urinary pregnancy test. When this resulted in a menstruation shortly afterwards, this was described as a biochemical pregnancy loss. A miscarriage was defined as a loss of a histologically or ultrasonographic recognized pregnancy in the first trimester. An ongoing pregnancy was diagnosed when fetal heart activity was present on ultrasound at 9 weeks of gestation.
Data analysis
We log-transformed non-normally distributed data prior to analysis. Primary analyses were performed using the Statistical Package for the Social Sciences version 12.0 (SPSS Inc., Chicago, IL, USA). Comparisons of characteristics and IVF outcomes between pregnant and non-pregnant women were performed using the t-test for continuous data and the x 2 -test for binary variables, unless stated otherwise.
A P-value ,0.05 was considered statistically significant. As reported previously, 26% of endometrial secretion samples showed minimal (19%), moderate (4%) or severe (3%) signs of blood contamination, which has been shown to affect the measurement of a number of cytokines (Boomsma et al., 2009) . The extent of blood contamination in the endometrial secretion samples was visually graded on a fourpoint scale (no, minimal, moderate, severe) and included as a covariate in the analyses. Blood contamination was not associated with the chance of conceiving (Boomsma et al., 2009) .
Multivariate analyses were applied since mutual correlations and molecular redundancy between the mediators are present. Concentrations of mediators were below the detection limit of the assay in a number of cases. Given that multivariate analyses only include cases with data from all included variables available, it was necessary to impute these missing data on the basis of the available measurements of the other cytokines in the panel. Data were imputed by WinBUGS (MRC Biostatistics Unit, Cambridge, UK), which allows the setting of conditions to the imputed data, since imputed data needed to be lower than the detection limit of each assay. Mediators with .50% of values missing were excluded from analyses, owing to a certain level of uncertainty of imputed data (Harrell, 2001) .
Multivariable logistic regression analysis was performed with a backward elimination procedure in S-Plus (Insightful Corporation) to identify factors predictive of embryo implantation or pregnancy. A P-value .0.1 was used as a criterion for exclusion according to the literature on multivariate prognostic modeling (Steyerberg et al., 2000) . Since this study was exploratory in nature, we have applied no correction for multiple testing as would be required for a hypothesis-based study. Thereafter, the following covariates were included in a forwardstepwise model: maternal age, embryo quality and blood contamination of the sample. Only covariates which significantly contributed to the model were included in the final analysis. The ability of this model of included factors and covariates to predict pregnancy was assessed by determining the area under the receiver operating characteristic (ROC) curve. In order to achieve a maximal and more reliable Figure 1 Wash-out curve of exogenous hCG in oocyte donors following administration of 10 000 IU hCG (Pregnyl) 36 h prior to oocyte retrieval. predictive ability (Steyerberg et al., 2000) , an ROC curve was also constructed for a panel of mediators that were selected by multivariable regression analysis with backward elimination with a relaxed criterion for exclusion, namely a P-value .0.3 rather than 0.1.
Results
Of the 248 women who consented to participate, 210 women underwent endometrial secretion aspiration prior to embryo transfer and were subjected to analysis (Fig. 2) . Sixty-eight women (32.4%) achieved a clinically recognized pregnancy. Univariate analysis comparing clinical parameters between pregnant and non-pregnant women showed pregnancy to be associated with a significantly higher number and quality of embryos available for transfer (Table I) . After embryo transfer for hCG measurements, 183 women collected urine samples to detect an implantation event. In four women, hCG analysis revealed atypical patterns which did not allow discrimination as to whether a pre-clinical pregnancy loss had occurred or not, and these data were excluded from further analysis. Figure 3 illustrates the outcome of the IVF/ICSI treatment and the incidence of preclinical pregnancy loss in 179 women. As detected by a rise in the urinary hCG level, 51.4% of embryo transfers resulted in embryo implantation. Of these implantations, 33.7% resulted in pre-clinical pregnancy loss, whereas the other implantations resulted in a clinically recognized pregnancy.
Intrauterine cytokine profile and outcome of IVF/ICSI
No discomfort or side effects of the aspiration were reported by any of the participants. In 99.5% of samples, sufficient material was obtained for analysis. Ten mediators (IL-1b, IL-6, IL-12, IL-18, TNF-a, MIF, eotaxin, MCP-1, IP-10, VEGF) were detectable in .90% of the samples. IL-15 was detectable in 76%, Dkk-1 in 68%, IL-10 in 56%, IL-17 in 54%, IL-5 in 35% and HbEGF in 23% of the samples. IFN-g was not detectable in any of the samples and we have previously shown that this was not due to technical problems (Boomsma et al., 2009) . Owing to the high number of missing values, HbEGF, IL-5 and IFN-g were excluded from further analyses. No significant differences in total protein content comparing samples from pregnant and non-pregnant women were found (P ¼ 0.5).
In order to determine the association between implantation or a clinical pregnancy and the cytokine profile in the secretions, multivariable logistic regression with backward stepwise elimination of the 14 included mediators was performed. Blood contamination, embryo quality and maternal age were entered as covariates into the analysis in a forward stepwise model. Since the contribution of blood contamination to implantation was not statistically significant, only embryo quality and maternal age were included in the final model. Multivariable logistic regression revealed a significant positive association between the concentration of IP-10 and embryo implantation (P ¼ 0.037), as well as a significant negative association between MCP-1 and implantation (P ¼ 0.005).
Implantation embraces both pre-clinical pregnancy losses and women achieving a clinical pregnancy. Therefore, the relation between the intrauterine cytokine profile and a clinical pregnancy was also assessed. The median concentration, and the 25th and 75th percentiles of concentrations of each mediator, identified in endometrial secretions from women who achieved a clinical pregnancy versus women who did not, are presented in Table II . Since embryo quality was the only covariate with a statistically significant contribution to pregnancy, only embryo quality was included in the final model. Multivariable logistic regression revealed a significant positive association between the concentration of TNF-a and clinical pregnancy (P ¼ 0.023), as well as a significant negative association between IL-1b and clinical pregnancy (P ¼ 0.047). Univariate analysis of individual mediators showed no significant associations with pregnancy. Interaction analysis showed no modifying effect of age on the relation of IL-1b and TNF-a with pregnancy. Second, and consistent with data from clinical studies (Daya and Gunby, 2004) , the type of luteal phase support did not predict pregnancy chances when added to a model containing IL-1b and TNF-a (P ¼ 0.47), nor did it change the significance of the two cytokines in the model. In order to identify a profile of mediators predictive of clinical pregnancy, the criterion for exclusion in the multivariable regression analysis was then relaxed (P-value .0.3 rather than 0.1). Four mediators were thus identified, namely IL-1b (P ¼ 0.058), TNF-a (P ¼ 0.030), MIF (P ¼ 0.27) and MCP-1 (P ¼ 0.22). Higher concentrations of IL-1b and MCP-1 were negatively associated with pregnancy, whereas those of TNF-a and MIF were positively associated with a clinical pregnancy.
The predictive value of endometrial secretion mediator concentrations for a clinical pregnancy was investigated by constructing an ROC curve. The area under the curve (AUC) for IL-1b and TNF-a levels as predictors of pregnancy was 0.61 [95% confidence interval (CI) 0.52-0.69], which is similar to the AUC for predicting pregnancy by embryo quality (0.61; 95% CI 0.54-0.68). Logistic regression analysis demonstrated that the combination of IL-1b, TNF-a and embryo quality was a significantly better predictor of pregnancy compared with embryo quality alone (P ¼ 0.049, likelihood ratio test), resulting in an AUC of 0.67 (95% CI 0.60-0.75) (Fig. 4) . Adding MCP-1 and MIF to IL-1b, TNF-a and embryo quality (AUC 0.69 95% CI 0.61-0.76) did not significantly improve the model (P ¼ 0.22, likelihood ratio test).
Discussion
The present study suggests that a molecular fingerprint of the receptive human endometrium can be identified in endometrial secretions aspirated immediately prior to embryo transfer. For the first time, a significant association between the concentrations of TNF-a and IL-1b in endometrial secretion during the window of implantation and the likelihood of a clinical pregnancy occurring in the same cycle has been shown.
Association between TNF-a and IL-1b and clinical pregnancy
Clinical pregnancy was associated with a significantly higher concentration of TNF-a in endometrial secretions. Previous data largely in women who collected urine samples 9 -19 days after oocyte retrieval (n ¼ 179).
Intrauterine cytokine profile and pregnancy derived from animal studies have indicated that TNF-a is a pro-inflammatory cytokine involved in triggering immunological pregnancy loss (Wegmann et al., 1993; Arck et al., 1997) . Our findings appear to be at odds with the prevailing paradigm that the establishment of pregnancy requires an anti-inflammatory cytokine milieu. However, this concept is now considered to represent an oversimplification of the immunological regulation of the tolerance of the conceptus, which requires more than a simple predominance of anti-inflammatory mediators (Chaouat et al., 2004) . Knock out studies in mice have shown that TNF-a may act as a protector of embryos exposed to teratogenic stress (Toder et al., 2003) . TNF-a has also been shown to be an important regulator of trophoblastic matrix metalloproteinase (MMP)-2 (Meisser et al., 1999) and MMP-9 (Meisser et al., 1999; Cohen et al., 2006) , which have been shown to mediate the invasive properties of trophoblastic cells into matrigel (Staun-Ram et al., 2004) . In the present study, clinical pregnancy was also associated with lower secretion levels of IL-1b. This finding is consistent with a previous report comparing women with implantation failure after IVF and controls, which demonstrated significantly higher IL-1b levels in endometrial flushings from women with implantation failure (Inagaki et al., 2003) . In addition, significantly lower levels of IL-1b mRNA in the endometrium of individuals with habitual abortion compared with fertile controls have been described (von Wolff et al., 2000) . It has been postulated that women with habitual abortion may have an 'over-receptive' endometrium resulting in recurrent miscarriages of abnormal embryos which were allowed to implant, rather than implantation failure of these embryos (Quenby et al., 2002) . However, others have suggested that IL-1b may play a facilitating role in implantation by up-regulation of integrins at the luminal epithelial surface (Simon et al., 1997) and MMPs (Karmakar and Das, 2002) , which mediate embryo adhesion and invasion. The observation that the levels of IL-1b and TNF-a are significantly related to achieving a clinical pregnancy and not embryo implantation suggests that these mediators may have a more important role in later stages of implantation rather than initial apposition and adhesion of the embryo. However, it should be emphasized that in the analysis of mediators correlated to implantation, IL-1b and TNF-a were only eliminated in the last steps of backward elimination in the logistic regression analysis. MCP-1, IP-10 and also MIF were eliminated in the last steps of elimination in the analysis on pregnancy, rather than implantation. Therefore, the results suggest a role for these mediators in both early and later steps of implantation, rather than a difference in mediators predictive of implantation and clinical pregnancy.
Association between MCP-1 and IP-10 and embryo implantation
Initial embryo implantation was observed to be significantly associated with endometrial secretion concentrations of MCP-1 (negatively) and IP-10 (positively). Both of these chemokines are known to play key roles in leukocyte migration (Jones et al., 2004) . Large populations of immune cells accumulate in the endometrium during the luteal phase and are believed to be important modulators of implantation.
There is evidence that a clear parallel can be established between the different steps in human embryo implantation and steps in leukocyte migration (Jones et al., 2004) . The embryo has been shown to express receptors for IP-10 and MCP-1 (Dominguez et al., 2003; Drake et al., 2004; Hanna et al., 2006) . MCP-1 is up-regulated by the administration of progesterone, and increased levels are found in secretory rather than proliferative endometrium (Caballero-Campo et al., 2002) . Moreover, MCP-1 has been shown to be a potent attractant and activator of uterine natural killer (uNK) cells (Loetscher et al., 1994) . High numbers of uNK cells have been related to miscarriage and infertility (Moffett et al., 2004) , which may be consistent with lower secretion levels of MCP-1 being associated with higher implantation rates, as observed in the present study.
Concentrations of IP-10 in endometrial secretions were positively associated with embryo implantation. IP-10 is primarily expressed in the human endometrium during the secretory phase, and uNK cells present during the luteal phase are potent secretors of IP-10 (Kitaya et al., 2004) . Evidence derived from animal studies also suggests a possible function for IP-10 in the process of implantation. The ability of uNK cells to induce trophoblast migration was shown to be significantly reduced by neutralizing antibodies to IP-10 in an in vivo model of human trophoblast migration in mice (Drake et al., 2004) . Moreover, IP-10 was demonstrated to stimulate the expression of integrin subunits in trophoblast cells, and recombinant IP-10 promoted adhesion of caprine trophoblast cells to endometrial epithelial cells (Nagaoka et al., 2003) .
Pre-clinical pregnancy loss
Studies of spontaneous conception have shown that a significant proportion of embryos which begin to implant fail to proceed to a clinically recognized pregnancy (Wilcox et al., 1999) . In the present study, the incidence of pre-clinical pregnancy losses was investigated by analyzing the incidence of urinary hCG rises (indicating inititiation of implantation) which did not lead to a subsequent positive pregnancy test. More than 50% of women undergoing embryo transfer demonstrated hCG rises indicating an implanting embryo. However, approximately one-third of these implantations resulted in pre-clinical pregnancy loss. One previous study has reported the incidence of preclinical pregnancy loss in an IVF population: 48% of the implanted embryos were shown to be lost before they were clinically recognized as a pregnancy (Simon et al., 1999) , compared with 34% in the present study. This difference in incidence may be due to differences in methodology and study population. The incidence of pre-clinical pregnancy loss in IVF cycles appears to be higher than that reported following spontaneous conceptions (Wilcox et al., 1988) . Although embryo quality is an important determinant of initial and ongoing implantations, the endometrium may also have a role. Specific endometrial factors may be involved in apposition and initial implantation, and others more important in facilitating later invasion. We therefore explored whether those markers present in the endometrial secretion predictive of implantation differed from those predictive of a clinical pregnancy. This was observed to be the case.
Limitations of the study
Endometrial secretion analysis at the time of embryo transfer offers certain essential advantages over other techniques. Most techniques require endometrial tissue, which is not possible to obtain during the window of implantation without disrupting the process of implantation (van der Gaast et al., 2003) . It is uncertain to what extent biopsies from the peri-ovulatory phase or preceding menstrual cycles reflect the mid-luteal endometrium in the study cycle. Studies of uterine cavity flushings have shown inconsistent data, possibly due to the high degree of dilution and differences in the timing of aspiration between the studies (Ledee- Bataille et al., 2002; Strowitzki et al., 2006) . Although it is a promising technique, endometrial secretion analysis has a number of limitations amenable to improvement. As yet, we have not been able to include certain proposed markers of the window of implantation in the multiplex immunoassay (Lessey et al., 1995; Chryssikopoulos et al., 1996; Ledee-Bataille et al., 2002) , either because appropriate antibodies were not available (glycodelin, osteopontin), or because of problems arising from crossinterference (IL-11, LIF and macrophage colony stimulating factor). In order to refine the array, novel potential markers for endometrial receptivity should be included in future studies. Endometrial secretions also contain cellular material, mostly epithelial and immune cells. In order to minimize interference in the assay by contaminating cells, the aspirate was centrifuged after dilution and the pellet was discarded. However, it should be recognized that the released contents of lysed cells also contribute to the intrauterine environment encountered by the embryo in vivo. At present, endometrial secretion analysis is not yet clinically useful to predict pregnancy.
Significance of findings and conclusions
Despite these limitations, we have for the first time identified profiles of mediators in aspirated endometrial secretions which are significantly correlated to implantation and to a clinically recognized pregnancy. Our results suggest that the ratio of TNF-a and IL-1b may serve as an indicator of endometrial receptivity, rather than individual absolute values of these mediators, since both coefficients are fairly similar in magnitude but opposite in direction. Interestingly, IL-1b and TNF-a are both pro-inflammatory cytokines. Pregnancy has been postulated to be an event requiring a predominance of anti-inflammatory mediators. However, implantation is a process of 'aggression' in which maternal and embryonic signals induce a state of controlled inflammation (van Mourik, 2009 ). Our findings, showing an important role for two pro-inflammatory mediators, endorse the view that the Th1/Th2 paradigm represents an over simplification of the role of cytokines as determinants of successful implantation (Chaouat et al., 2004) . ROC analysis showed that the ability to predict clinical pregnancy by IL-1b and TNF-a levels in endometrial secretions was similar to the predictive value of embryo quality. Although the predictive value of the markers selected in the present study is too low to be clinically useful, it is noteworthy that the predictive values of the cytokine secretion profile and embryo quality were 'additive', indicating that the endometrium is not simply facilitatory in the implantation process, but is also itself an independent determinant of outcome. The present study has also emphasized the importance of chemokines at the fetal -maternal interface, presumably as a result of their function in leukocyte and embryo migration. Since our study is exploratory in nature, we have applied no correction for multiple testing as would be required for a confirmatory hypothesis-based study. Our results require confirmation, and the array should be further refined. Moreover, issues such as inter-cycle and intra-cycle variation in secretion patterns should be explored. The intrauterine milieu in natural cycles of normal fertile women is also interesting to explore. However, this may be considered ethically difficult given the risk of possibly aspirating an embryo already present in the uterus. The noninvasive nature of endometrial secretion analysis enables endometrial receptivity to be investigated prior to embryo transfer in IVF cycles using pregnancy as an end-point, rather than surrogate markers for endometrial receptivity, such as endometrial dating by histology. Employing this novel approach will increase our understanding of the complex molecular cross-talk by which the embryo engages the intrauterine environment.
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